Abstract:ABSTRACT The antibacterial activity of rifamycins specifically relies on the inhibition of transcription by directly binding to the β-subunit of bacterial DNA-dependent RNA polymerase (RNAP). However, its killing efficacy is substantially diminished in most gram-negative bacteria. To systematically reveal the cellular functions that counteract rifamycin-mediated killing in the gram-negative model organism Escherichia coli , we performed a genome-wide Tn5 transposon-mediated screen to identify mutants with altered susceptibility to rifampicin. Combined with targeted gene knockouts, our results showed that the β-barrel assembly machinery plays a crucial role in restricting rifampicin from entering the cell, whereas mutants deficient in other cellular permeability barriers, such as lipopolysaccharide and enterobacterial common antigen, had no such effect. At bactericidal concentrations, the killing efficacy of rifampicin was strongly influenced by cellular functions, including iron acquisition, DNA repair, aerobic respiration, and carbon metabolism. Although iron acquisition de facto has a strong impact or dependence on cellular redox, our results suggest that their effects on rifampicin efficacy do not rely on hydroxyl radical formation. We provide evidence that maintenance of DNA replication and transcription-coupled nucleotide excision repair protects E. coli cells against rifampicin killing. Moreover, our results showed that sustained aerobic respiration and carbon catabolism diminish rifampicin’s killing efficacy, and this effect relies on the inhibition of transcription but not on translation. These findings suggest that the killing efficacy of rifamycins is largely determined by cellular responses upon the inhibition of RNAP and may expand our knowledge of the action mechanisms of rifamycins. IMPORTANCE Rifamycins are a group of antibiotics with a wide antibacterial spectrum. Although the binding target of rifamycin has been well characterized, the mechanisms underlying the discrepant killing efficacy between gram-negative and gram-positive bacteria remain poorly understood. Using a high-throughput screen combined with targeted gene knockouts in the gram-negative model organism Escherichia coli , we established that rifampicin efficacy is strongly dependent on several cellular pathways, including iron acquisition, DNA repair, aerobic respiration, and carbon metabolism. In addition, we provide evidence that these pathways modulate rifampicin efficacy in a manner distinct from redox-related killing. Our findings provide insights into the mechanism of rifamycin efficacy and may aid in the development of new antimicrobial adjuvants.

Evolution and evolvability of rifampicin resistance across the bacterial tree of life

Evolution of Escherichia coli rifampicin resistance in an antibiotic-free environment during thermal stress

High-resolution landscape of an antibiotic binding site

The development of variation-based rifampicin resistance in Staphylococcus aureus deciphered through genomic and transcriptomic study

Selective Pressure by Rifampicin Modulates Mutation Rates and Evolutionary Trajectories of Mycobacterial Genomes

Rifampicin-Resistance Mutations in the Rpob Gene in Bacillus Velezensis CC09 Have Pleiotropic Effects.

rpoB mutations conferring rifampicin-resistance affect growth, stress response and motility in Vibrio vulnificus

Genome-wide screen reveals cellular functions that counteract rifampicin lethality in Escherichia coli

Detection of Rifampicin-Resistance Mutations in Mycobacterium Tuberculosis

Rifampin Resistance Mutations in the Rpob Gene of Enterococcus Faecalis Impact Host Macrophage Cytokine Production.

Conserved Evolutionary Trajectory Can Be Perturbed to Prevent Resistance Evolution under Norfloxacin Pressure by Forcing Mycobacterium smegmatis on Alternate Evolutionary Paths

Global Effect of an RNA Polymerase Β-Subunit Mutation on Gene Expression in the Radiation-Resistant Bacterium Deinococcus Radiodurans

Compensatory evolution in NusG improves fitness of drug-resistant M. tuberculosis

Low-Level Rifampin Resistance and rpoB Mutations in Mycobacterium tuberculosis: an Analysis of Whole-Genome Sequencing and Drug Susceptibility Test Data in New York

Evolutionary trajectories of β-lactam resistance in strains

Evolutionary trajectories of β-lactam resistance in Enterococcus faecalis strains

Mechanisms of Staphylococcus Aureus Antibiotics Resistance Revealed by Adaptive Laboratory Evolution

Predicting the evolution of antibiotic resistance

The Evolution of Heteroresistance via Small Colony Variants in Escherichia coli Following Long Term Exposure to Bacteriostatic Antibiotics

Molecular Characterization of Rifr Mutations in Enterococcus Faecalis and Enterococcus Faecium.

Exceptions to the rule: When does resistance evolution not undermine antibiotic therapy in human bacterial infections?